Now, Cleveland Clinic researchers may have figured out which patients have the best odds of success. Women who take Wegovy to treat obesity have the greatest likelihood of achieving 10% or more weight ...

Some weight-loss and diabetes drugs can treat obesity when combined with exercise, a healthy diet, and counseling, according to WHO's first guidance on these medicines. The recommendations come amid ...

The weight-loss drug liraglutide helped obese children lower their BMI and reach a healthier weight, researchers report. The findings, published Tuesday in the New England Journal of Medicine and ...

The World Health Organization on Monday released new guidance on GLP-1 medications for adults with obesity, recommending ...

A study showing that once-weekly subcutaneous semaglutide 2.4 mg (Wegovy, Novo Nordisk) produces greater long-term weight loss than once-daily injected liraglutide 3.0 mg (Saxenda, Novo Nordisk) among ...

The GLP-1 receptor agonist, which was first approved for adults in December 2014, is now a treatment option for adolescents with obesity ages 12-17 as adjunct to diet and exercise. More specifically, ...

Saxenda is a brand name for the weight loss injectable medicine, Liraglutide. It was approved by the FDA for weight loss nearly a decade ago. Saxenda has been labeled ‘the skinny jab’ and the ‘miracle ...

In a comparison of injectable GLP-1 receptor agonists, semaglutide (Wegovy) appeared to edge out liraglutide (Saxenda) when it came to weight loss, according to the phase IIIb STEP 8 study. In a ...

Generic Saxenda® is the first-ever generic GLP-1 indicated for weight loss, addressing increased demand for this category of therapies in the U.S. market. This approval and launch add to Teva’s ...

Carlene Johnson, a 48-year-old Boston resident, couldn’t remember a time when she didn’t feel hungry. Even after eating a full meal, she felt like she needed to eat again just minutes later. She tried ...

Lexaria has now demonstrated, in distinct human clinical studies, clear reductions in AEs utilizing its patented DehydraTECH technology with all of the three major GLP-1 drugs sold in the world today: ...

Saxenda (liraglutide) is a GLP-1 agonist injection pen medication. It helps with sustained weight loss for adults with obesity, adults with overweight who are experiencing weight-related health issues ...